165 related articles for article (PubMed ID: 4131652)
21. [Serum acid phosphatase levels following prostatic massage (author's transl)].
Chiari R; Harzmann R; Züge E; Allner R
Urol Int; 1976; 31(3):191-7. PubMed ID: 60817
[TBL] [Abstract][Full Text] [Related]
22. Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia.
Rackley RR; Yang B; Pretlow TG; Abdul-Karim FW; Lewis TJ; McNamara N; Delmoro CM; Bradley EL; Kursh E; Resnick MI
Cancer; 1991 Aug; 68(3):587-93. PubMed ID: 1712242
[TBL] [Abstract][Full Text] [Related]
23. Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia.
Vicentini C; Gravina GL; Angelucci A; Pascale E; D'Ambrosio E; Muzi P; Di Leonardo G; Fileni A; Tubaro A; Festuccia C; Bologna M
J Cancer Res Clin Oncol; 2004 Apr; 130(4):217-21. PubMed ID: 14749923
[TBL] [Abstract][Full Text] [Related]
24. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Bauer HW; Schmeller NT
Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
[TBL] [Abstract][Full Text] [Related]
25. An assessment of serum acid and alkaline phosphatase determinations in prostatic cancer with a clinical validation of an acid phosphatase assay utilizing adenosine 3'-monophosphate as substrate.
Goldberg DM; Ellis G
J Clin Pathol; 1974 Feb; 27(2):140-7. PubMed ID: 4132966
[TBL] [Abstract][Full Text] [Related]
26. [Histochemical characterization of different tissue enzymes in prostate adenomas and carcinomas].
Hajek J; Papousek F; Nemecek R; Hanselova M; Strmiska M
Acta Urol Belg; 1985; 53(1):96-100. PubMed ID: 2581425
[No Abstract] [Full Text] [Related]
27. Leucine-arylamidase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
Verlooy J; van Sande M; Van Camp K
Acta Urol Belg; 1981 Oct; 49(4):491-5. PubMed ID: 6172970
[No Abstract] [Full Text] [Related]
28. Prostatic acid phosphatase and prostatic cancer.
Foti AG; Cooper JF; Herschman H
Recent Results Cancer Res; 1979; 67():45-9. PubMed ID: 88065
[No Abstract] [Full Text] [Related]
29. Radioimmunoassay (RIA) for prostatic acid phosphatase in patients with prostatic carcinoma.
Debruyne FM; van Munster PJ; van Groeninghen JC; Kirkels WJ
Urol Res; 1984; 12(5):233-7. PubMed ID: 6083652
[TBL] [Abstract][Full Text] [Related]
30. Effect of digital manipulation of the prostate on serum acid phosphatase levels in man.
Pendse AK; Prakash RO; Babel AL
Indian J Med Res; 1981 Sep; 74():479-81. PubMed ID: 6172376
[No Abstract] [Full Text] [Related]
31. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
[TBL] [Abstract][Full Text] [Related]
32. Study of activities of arginase, hexosaminidase, and leucine aminopeptidase in prostate fluid.
Vafa AZ; Grover PK; Pretlow TG; Resnick MI
Urology; 1993 Aug; 42(2):138-43. PubMed ID: 7690169
[TBL] [Abstract][Full Text] [Related]
33. Measurement of prostate-specific antigen and prostatic acid phosphatase concentrations in serum before and 1-42 days after transurethral resection of the prostate and orchidectomy.
Price A; Attwood SE; Grant JB; Gray TA; Moore KT
Clin Chem; 1991 Jun; 37(6):859-63. PubMed ID: 1710953
[TBL] [Abstract][Full Text] [Related]
34. [Determination of tumor markers in the diagnosis of prostatic cancer].
Casas Terrón E; Mari Ruiz M; Molina Andreu E
Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
[TBL] [Abstract][Full Text] [Related]
35. Circadian and day-to-day variation of prostatic acid phosphatase.
Nissenkorn I; Mickey DD; Miller DB; Soloway MS
J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
[TBL] [Abstract][Full Text] [Related]
36. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES].
MICHON J
Acta Urol Belg; 1964 Jan; 32():85. PubMed ID: 14111385
[No Abstract] [Full Text] [Related]
37. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES].
BRENEZ J
Acta Urol Belg; 1964 Jan; 32():100-3. PubMed ID: 14111370
[No Abstract] [Full Text] [Related]
38. The effect of prostatic massage on acid phosphatase in patients with and without benign prostatic hypertrophy.
Glazener CM; Pringle R
Br J Clin Pract; 1982 Sep; 36(9):305-6. PubMed ID: 6185127
[No Abstract] [Full Text] [Related]
39. Alterations in serum lactate dehydrogenase activity and its isoenzyme pattern after massage of the prostate. Value in differentiating carcinoma from benign hyperplasia of the prostate.
Ishibe T
Invest Urol; 1971 Sep; 9(2):104-8. PubMed ID: 5120368
[No Abstract] [Full Text] [Related]
40. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia.
Kucur M; Isman FK; Balci C; Onal B; Hacibekiroglu M; Ozkan F; Ozkan A
Urol Oncol; 2008; 26(1):47-52. PubMed ID: 18190830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
